Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer
Status:
Terminated
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn about the safety and effectiveness of
OSI-774 when combined with standard chemotherapy (carboplatin and paclitaxel) before surgery
in the treatment of non-small cell lung cancer.